SCHEMBL21705041

SCHEMBL21705041

c1ccc(C(c2ccccc2-c2cc3ccccc3cn2)c2ccccc2-c2cc3ccccc3cn2)c(-c2cc3ccccc3cn2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.61
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ RAB9A P51151 3/20 0.45
▸ CYP1A2 P05177 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ BTK Q06187 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ PDPK1 O15530 1/20 0.42
▸ MIF P14174 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ GRM4 Q14833 1/20 0.36
▸ PLAU P00749 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28271036 0.84 NPC1 (0.74) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL23599072 0.79 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL5470573 0.77 NPC1 (0.63) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL31175948 0.76 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL13818451 0.76 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL731645 0.76 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL807820 0.76 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL3832405 0.76 NPC1 (0.62) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL21173257 0.73 NPC1 (0.59) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL13985938 0.72 NPC1 (0.68) NPC1L3MBTL1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048289-A1 PROCESS FOR PREPARING ORTHO-METALLATED METAL COMPOUNDS MERCK PATENT GMBH (DE) 2020-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048289-A1 PROCESS FOR PREPARING ORTHO-METALLATED METAL COMPOUNDS NISCH, SOD1, MDM4 NPC1 4206/4885L3MBTL1 2290/4885CASP3 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback